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Crystal structure of the wide-spectrum binuclear zinc
b-lactamase from Bacteroides fragilis
Nestor O Concha1, Beth A Rasmussen2, Karen Bush2 and Osnat Herzberg1*
Background: The metallo-b-lactamase from Bacteroides fragilis hydrolyzes a
wide range of b-lactam antibiotics, and is not clinically susceptible to any known
b-lactamase inhibitors. B. fragilis is associated with post-surgery hospital
infections, and there has been a recent report of plasmid-mediated dissemination
of the enzyme. Effective inhibitors are therefore urgently needed. Knowledge of
the three-dimensional structure will aid in the drug design effort.
Results: The crystal structure of the enzyme has been determined by using
multiwavelength anomalous diffraction at the zinc absorption edge and 
refined to 1.85 Å resolution. The structure is a four-layer a/b/b/a molecule. The
active site, found at the edge of the b sandwich, contains a binuclear zinc center
with several novel features. One zinc is tetrahedrally coordinated, the other 
has a trigonal bipyramidal coordination; a water/hydroxide molecule serves 
as a ligand for both metals. The residues that coordinate the two zincs are
invariant in all metallo-b-lactamases that have been sequenced, except for two
conservative replacements. Despite the existence of the pattern for binuclear
zinc binding, the reported structure of the Bacillus cereus enzyme contains only
a single zinc.
Conclusions: Structural analysis indicates that affinity for the penta-coordinated
zinc can be modulated by neighboring residues, perhaps explaining the absence
of the second zinc in the B. cereus structure. Models of bound substrates suggest
that the active-site channel can accommodate a wide variety of b-lactams. We
propose that the zinc cluster prepares an hydroxide, probably the hydroxide that
ligates both zincs, for nucleophilic attack on the carbonyl carbon atom of the
b-lactam. The resulting negatively charged tetrahedral intermediate implicated in
catalysis is stabilized by an oxyanion hole formed by the side chain of the invariant
Asn193 and the tetrahedral zinc.
Introduction
b-Lactam antibiotics are effective and widely used com-
pounds against pathogenic bacterial infections. They inacti-
vate key enzymes of the bacterial cell wall synthesis and
repair pathways, leading to defective cell walls and, eventu-
ally, cell death [1]. It is the production of b-lactamases [2],
enzymes that catalyze the hydrolysis of the amide bond of
the b-lactam ring, that provides the major bacterial defense
mechanism against this type of antibiotic. On the basis of
amino acid sequence homology, b-lactamases have been
divided into four classes, A–D [3–5]. Classes A, C and D
share an active-site serine residue and are collectively
termed the serine b-lactamases. The hydroxyl group of the
serine residue mounts the nucleophilic attack on the car-
bonyl carbon atom of the b-lactam ring. In contrast, the class
B enzymes require metal ions for catalytic activity [6,7], and
their amino acid sequences lack the Ser-X-X-Lys fingerprint
typical of the active sites of the serine b-lactamases [8–14].
In vivo, class B b-lactamases probably function in the Zn2+-
bound form, but activity is also observed in the Cd2+- or
Co2+-bound forms of the enzyme [7,15,16]. By analogy with
other metallo-hydrolases [17,18], the catalytic mechanism
may involve a hydrolytic water molecule with enhanced
nucleophilicity due to its proximity to the metal ion.
The first metallo-b-lactamase to be identified was from
Bacillus cereus. For as long as this enzyme was the only
metallo-b-lactamase known, the class B enzymes were con-
sidered somewhat obscure and posed little clinical threat.
With the rapid identification of new metallo-b-lactamases
and the realization that they can hydrolyze a wide range of
substrates, including cephamycins and imipenem that are
resistant to the serine b-lactamases [16,19–21], the clinical
risks became apparent. Moreover, the metallo-enzymes
show little or no susceptibility to traditional b-lactamase
inhibitors, such as clavulanic acid or sulbactam [16,19]. The
metallo-enzymes are inhibited by the metal chelators
EDTA and 1,10-o-phenantroline [6,7,14–16,22, 23], but it is
yet to be shown that these can be used as lead compounds
for the development of specific inhibitors. The antibiotic
tazobactam inactivates metallo-b-lactamases, but not at a
level that is clinically useful [24].
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To date, the amino acid sequences of metallo-b-lactamases
from B. cereus [8], Bacteroides fragilis [9,10], Aeromonas
hydrophila [11,12], Xanthomonas maltophilia [13], and Serra-
tia marcescens [14] have been determined. Only the first
four proteins share a level of sequence identity indicative
of an evolutionary relationship (25–37% identity). Thus, as
more sequences of metallo-b-lactamases become available
reclassification may be required.
Early work on the metallo-b-lactamase from B. cereus indi-
cated that the enzyme binds one zinc ion with high affinity,
and a second with much lower affinity (with a Kd in milli-
molar range) [7]. Substrate hydrolysis correlated mostly
with the metal binding at the site of higher affinity; spec-
troscopic measurements implicated a cysteine residue in
metal binding [7]. 1H NMR spectroscopy further impli-
cated three histidine residues as ligands of the high affinity
metal ion, and a fourth histidine as a ligand of the low affin-
ity metal ion [25]. More recently, the determination of the
crystal structure of the enzyme from B. cereus revealed 
a single Zn2+ coordination to three invariant histidine
residues [26]. The crystal structure also showed that the
Zn2+ binds at the interface between two b sheets, and sug-
gested that an invariant aspartate residue, Asp90, located
close to the Zn2+ acts as the general base that accepts the
proton from the hydrolytic water molecule.
The metallo-b-lactamases that have been studied span a
wide range of catalytic efficiencies [27]. The enzymes with
the narrowest specificity profile are from the group of
Aeromonas species. The enzyme from A. hydrophila has only
two good substrates, imipenem and ampicillin, and it is
inhibited by cefoxitin [19,20]. Its ability to hydrolyze
imipenem, a penicillin with an a-substituent on the b-
lactam ring, is the main cause of concern. The B. fragilis
enzyme, the subject of this study, exhibits the broadest
spectrum for different substrates and the most efficient
activity [16,19–21]. kcat/Km values for a sample of 25 peni-
cillins and cephalosporins vary from ~105 to ~107 M–1s–1 [16].
B. fragilis, a gram-negative anaerobe, is considered one of
the most important pathogens in polymicrobial infections
in humans [28–30]. The proliferation of the bacteria in
nosocomial infections, combined with the broad-spectrum
substrate profile of its metallo-b-lactamase, the lack of
potent inhibitors, and the report of plasmid-mediated
dissemination of the enzyme [31] (K Bandoh, W Watan-
abe, Y Muto, Y Tanaka, N Kato, K Ueno, [abstract 945],
31st Interscience Conference on Antimicrobial Agents and
Chemotherapy, Tokyo, 1991) underscore the need for
better understanding of the catalytic mechanism and the
basis for substrate specificity. We present here, the refined,
high resolution crystal structure of the B. fragilis metallo-
b-lactamase, showing that the active site contains a
binuclear (Zn2+-Zn2+) center. The three-dimensional view
of the active site together with modeling of bound
substrates provide the structural basis for future drug
design efforts.
Results and discussion
Quality of the model
The soluble polypeptide chain of the metallo-b-lactamase
from B. fragilis consists of residues 18–249 (the first 17
amino acids constitute the signal peptide). The crystal
structure provides two crystallographically independent
views of the molecule, termed A and B. These are related
to each other by a non-crystallographic rotation axis of
179.6°. The model for molecule B includes all the amino
acid residues except for 48 and 49, which are associated
with a region of low electron density. In molecule A, these
two residues and the first two N-terminal residues are
disordered. The model includes a total of 527 water mol-
ecules, two zinc ions and one sodium ion per molecule.
The crystallographic R factor (R=Sh||Fo|-|Fc||/Sh|Fo|,
where |Fo| and |Fc| are the observed and calculated struc-
ture factor amplitudes, respectively) is 0.167 for 34 597
reflections in the resolution range 8.0–1.85 Å for which
F>2s(F). The estimated mean coordinate error is 0.2 Å, as
calculated with SIGMAA [32]. The root mean square
(rms) deviation from ideal bond length and bond angle
values of the standard geometry, compiled by Engh and
Huber [33], are 0.02 Å, and 1.9°, respectively. The rms
difference between the a carbon atom positions of the two
molecules in the asymmetric unit is 0.5 Å [34]; the largest
differences are at residues Ile24–Asp26 (4.7 Å difference
at Asp26). Two other large differences between the two
molecules occur at Glu47, adjacent to the disordered
dipeptide 48–49 (1.2 Å difference), and at the C-terminal
Pro249 (2.8 Å difference). These differences are associ-
ated with regions of high crystallographic temperature
factors. Residues Ile24–Asp26, located remotely from the
active site, are involved in crystal contacts in molecule A
but not in molecule B. It is the difference in the local
environment that determines which conformation has
been adopted. The environment in molecule A is deter-
mined by two key interactions: a water molecule bridging
the two carboxylate groups of a symmetry related Asp26
pair; and an intermolecular contact between Ser25 Og and
Met51 Sd (3.0 Å). In contrast, both Asp26 and Ser25 
of molecule B form intramolecular interactions. The car-
boxylate group of Asp26 interacts with the amino group 
of Lys23, and Ser25 Og interacts with Ile28 N. When 
the deviating residues listed above are omitted from 
the comparison, the rms difference between the two
molecules is 0.3 Å.
Overall structure
The metallo-b-lactamase from B. fragilis is an a+b protein
(Fig. 1), of the four-layered a/b/b/a class. However, the
topology of this enzyme is quite distinct from some other
members of this class, including DNase I [35], exonucle-
ase III [36], and the N-terminal nucleophile family [37].
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Figure 1
The fold of B. fragilis metallo-b-lactamase.
(a) Ribbon diagram highlighting secondary
structure motifs. Helices and b strands are
colored blue and gold, respectively. The zinc
metal ions in the active site are shown as red
spheres and are located at the top edge of the
b sandwich. The dotted line corresponds to the
positions of the two conformationally
disordered residues (48 and 49) in the vicinity
of the active site. (The figure was generated
with Molscript [69] and rendered with
Raster3D [70] using the 2.0 version [71] and a
TCL-TK front-end developed by H Gilson
[unpublished program].) (b) Stereoscopic
representation of the trace of the Ca atom
positions, shown in the same orientation as (a).
The position of every tenth residue is
numbered. (c) Topographical diagram of the
arrangement of the secondary structure
elements of b-lactamase. Triangles represent
b strands and circles represent a helices, the N
and C termini are marked. To indicate that it is
not part of the a/b layer a3 is shown in white.
Consistent with the amino acid sequence homology, the
overall fold of the metallo-β-lactamase is the same as that
of the enzyme from B. cereus [26]. However, an additional
b strand (b8 in Fig. 1c) has been assigned in the N-termi-
nal sheet of the B. fragilis metallo-b-lactamase and the
topology scheme is not the same. This probably reflects
differences in topology analysis rather than genuine dif-
ferences in the tracing of the polypeptide chain. For
example, a3 in the current study is not part of the b sand-
wich, and a4 and a5 are depicted as being antiparallel.
Carfi et al. [26] discussed the symmetry between the two
a/b layers. However, the symmetry is not exact; the pair
of helices that pack against the sheet of the N-terminal
a/b layer (a1 and a2 in Fig. 1c) run parallel to each other,
whereas the equivalent helices (a4 and a5) that pack
against the C-terminal b sheet run antiparallel to each
other. The last two strands of the first b-sheet, b7 and b8
are connected by a large helix-containing loop, with the
helix (a3) running perpendicular to the b-sheet and not
contacting the first two helices.
The interfaces between sheet and helices, and between
the two sheets are dominated by hydrophobic interactions.
However, the packing is not perfect and a total of six
water molecules and a sodium cation, that are inaccessible
to bulk solvent, were observed underneath the lining of
the active-site depression. These molecules occupy three
distinct cavities. The largest cavity contains three water
molecules and the sodium cation, the second to the largest
contains two water molecules, and the smallest cavity is
occupied by a single water molecule. Asp69, which as dis-
cussed later exhibits an unusual conformation, is wedged
between the two former cavities. The buried solvent mol-
ecules and Asp69 may have functional role, this is yet to
be investigated.
The active site
The loops which connect secondary structure units on one
side of the molecule (located at the bottom in the view pre-
sented in Fig. 1a,b) are systematically shorter, compared
with the more extensive loops on the opposite side (top of
Fig. 1a,b). The active site is associated with the region con-
taining the large loops, at the edge of the b sandwich. The
location of the active site in the crystal structure of the
metallo-b-lactamase from B. cereus is the same, except that
it only contains one zinc [26], in contrast to the B. fragilis
enzyme which contains two zinc ions. All amino acid
residues that coordinate to the two zinc ions reside on
loops and turns. Interestingly, the location of the metal ion
in exonuclease III [36] is similar, despite differences in the
topology. Similarly, the active site of the N-terminal nucle-
ophile family is also observed within the interface between
the two b sheets [37].
The two zinc ions are located 3.5 Å apart, at the bottom of
a groove (Fig. 2). The first zinc ion, Zn1, is coordinated to
four ligands in a tetrahedral geometry (Table 1, Fig. 3);
three histidine residues (His99 Nε, His101 Nδ, and His162
Nε) and a solvent molecule that has been refined as a
water (Wat1). The second zinc, Zn2, is coordinated to five
ligands in a distorted trigonal bipyramidal geometry: three
protein residues (Asp103 Oδ2, Cys181 Sγ and His223 Nε);
and two water molecules (Wat1 and Wat2). The apical
positions of the trigonal bipyramid are occupied by Asp103
Oδ2 and Wat2 (termed the apical water throughout), and
the equatorial positions are occupied by Cys181 Sγ, His223
Nε, and Wat1. The proximity of Wat1 to both zinc ions
indicates that most likely this is a hydroxide (termed the
shared hydroxide). In addition to coordination to the two
zinc ions, the shared hydroxide forms an electrostatic
interaction with Asp103 Oδ1 indicating that they share a
proton. Finally, Cys181 is presumably also negatively
charged. This is the first example of a cysteine residue that
coordinates to a zinc ion in a binuclear zinc center.
There are intricate electrostatic interactions between the
zinc ligands and nearby protein groups and solvent mol-
ecules that assure the precise positions and orientations of
the ligands. The type of electrostatic interactions between
the imidazole groups (His99, His101, His162 and His223)
and other protein residues is consistent with there being a
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Figure 2
The active site of the B. fragilis metallo-b-lactamase. The molecular
surface of the enzyme is depicted together with a model of a bound
molecule of benzylpenicillin (colored red). The benzyl side chain fits
into a hydrophobic pocket. The zinc ions are represented as magenta
spheres and two key water molecules as blue spheres. The disordered
residues, 48 and 49, and the side chain of Glu50 are colored light
blue. (The figure was generated with GRASP [72].) 
protonated form of each of the non-coordinating nitrogen
atoms: His99 Nδ interacts with Asn98 Oδ (2.7 Å) (while
Asn98 Nδ interacts with Ile167 O, 2.7 Å); His101 Nε
interacts with Asp196 Oδ (2.7 Å); His162 Nδ interacts with
a water molecule Wat7 (3.0 Å) which in turn interacts with
the two main-chain carbonyl oxygen atoms of Ile191
(2.8 Å) and Asn193 (2.8 Å); His223 Nδ interacts with
Ser53 O (2.8 Å). The non-histidine protein ligands,
Cys181 and Asp103, interact with tightly bound internal
water molecules, and this may help modulate their charge
state. Cys181 is bridged by Wat9 to the carboxylate group
of Asp69 (3.2 Å), and Asp103 interacts with Wat11 (2.7 Å).
Watt 11 in turn interacts with the sodium cation that forms
a buried ion pair with the Asp69 carboxylate group. The
second molecule in the asymmetric unit exhibits the same
arrangement of coordination and second shell interactions.
Zinc clusters have been observed in the active sites of
other enzymes [38]. Seven structures that contain at least
two zinc ions have been examined: alkaline phosphatase
[39]; phosphotriesterase [40]; Klenow fragment of DNA
polymerase I [41]; P1 nuclease [42]; phospholipase C [43];
aminopeptidase [44]; and leucine aminopeptidase [45].
The distance between a pair of zinc ions in these struc-
tures varies between 2.9–3.9 Å, thus the distance observed
in the b-lactamase structure is well within this range
(3.5 Å). Although the arrangement of ligands in the B.
fragilis enzyme is unique among binuclear zinc enzymes,
there is one notable common feature; there is always a
negatively charged group, either a carboxylate, a hydrox-
ide or a phosphate anion shared by the two zinc ions. 
The structurally-based amino acid sequence alignment of
the various metallo-b-lactamases reveals that most, if not
all, enzymes contain the hallmark for a binuclear-zinc
center (Fig. 4). Conforming to the numbering scheme of
the b-lactamase from B. fragilis, three ligands are located
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Table 1
Zinc ligands.*
Zn1 (tetrahedral)‡ Zn2 (trigonal bipyramidal)§
His99 Ne 2.1/2.2 Asp103 Od† 2.3/2.1
His101 Nd 2.0/2.1 Cys181 Sg 2.3/2.4
His162 Ne 2.0/2.0 His223 Ne 2.1/2.2
Wat1/Wat3† 1.9/1.9 Wat1/Wat3† 2.1/2.2
Wat2/Wat4 2.3/2.2
*Distances to the metal (in Å) are quoted for the two molecules in the
asymmetric unit. Wat1 and Wat2 bind to molecule A and Wat3 and
Wat4 bind to molecule B. †Distances between Asp103 Od1 and
Wat1/Wat3 are 2.7/2.5 Å. ‡Average ligand–Zn–ligand angle, 109°.
§Average ligand–Zn–ligand angle for equatorial atoms (Cys181 Sg,
His223 Ne and Wat1), 120°; angle between ligands at the apices
(Asp103 Od and Wat2), 164°; average angle between ligands at the
apices and equatorial ligands, 90°.
Figure 3
The environment of the binuclear zinc centre in
the metallo-b-lactamase from B. fragilis.
(a) Stereoscopic representation of the atomic
model of the active site. The zinc and metal-
bound solvent molecules are represented as
magenta and turquoise spheres, respectively.
The color-coding used in this figure is used
throughout. Main-chain bonds are colored gray,
negatively charged residues are colored in
varying intensities of red, positively charged
residues are in purples, hydrophobic residues
in greens, browns and yellows, and hydrophilic
residues are shown in pinks and oranges.
Zinc–ligand interactions are shown as orange
dotted lines. Other key electrostatic
interactions are shown as gray dotted lines.
Zn1 is tetrahedrally coordinated and Zn2 is
penta-coordinated. The two water molecules
are labeled Wat 1 and Wat 2. (b) Stereoscopic
view of the electron-density map in the vicinity
of the active site. The coefficients 2Fo–Fc and
calculated phases are used. The map is
contoured at 1.2σ level.
on a short peptide (starting at residue 99) with the consen-
sus sequence His-X1-His-X1-Asp. The two histidine
residues (with the exception of the A. hydrophilia enzyme
where the first histidine is replaced by an asparagine
residue) coordinate to the tetrahedral zinc, Zn1; the invari-
ant aspartate is a ligand of the penta-coordinated zinc,
Zn2. The remaining three ligands are also invariant in all
known sequences, with the exception of the enzyme from
X. maltophilia where the cysteine ligand is replaced by an
aspartate. This is a conservative replacement because a
cysteine that is coordinated to zinc probably exists in the
thiolate form.
The same finger print for a binuclear zinc center is found
in the sequence of the B. cereus b-lactamase, yet the crystal
structure contains only one zinc ion [26] at a position
equivalent to Zn1 of the B. fragilis enzyme. The electron-
density map around the zinc reveals a weak density, which
was attributed to a water molecule. This weak density was
at approximately the same position as that of the penta-
coordinated zinc, Zn2, in the B. fragilis enzyme. The
authors proposed that this is the hydrolytic water.
Equilibrium dialysis and 1H NMR data for the metallo-b-
lactamase from B. cereus [7,25], identified a large differ-
ence between the dissociation constants of the high and
low affinity zinc-binding sites (2.4 µM and 24 mM). These
data were obtained at low pH, pH 5.3 for the high affinity,
and pH 5.7 for the low affinity sites. In addition, the
solutions used in the experiments were buffered by succi-
nate, which could chelate the low affinity zinc. These
conditions could reduce zinc affinity and change the
protonation states of the ligands. The crystals of the
B. cereus enzyme were obtained at pH 5.6 in the presence
of 100 µM ZnSO4, much below the concentration required
to saturate the second zinc-binding site. Citrate, also a
chelator of zinc ions, was used to buffer the solutions. 
In contrast, the crystals of the B. fragilis enzyme were
obtained at pH 7.0 and in the presence of only 10 µM
ZnCl2. Nevertheless, it is the binuclear zinc center that is
observed in the active site, indicating that both sites are
high affinity sites. The intriguing discrepancy between
the two structures may be the consequence of the differ-
ence in experimental conditions, or may reflect a genuine
difference in affinities. The local electrostatic environ-
ment in the active site of the B. cereus enzyme may result
in a lower affinity for the second zinc ion to bind. One can-
didate for such an effect emerges when the aligned amino
acid sequences of the two enzymes are analyzed in the
contexts of the structure of the B. fragilis enzyme, and the
view of the active site of the B. cereus enzyme provided by
Carfi et al. [26]. Such analysis shows the second cysteine
residue, Cys104, in the B. fragilis b-lactamase to be
replaced by an arginine residue in the B. cereus enzyme.
Cys104 is located in the vicinity of the active site, less
than 6 Å away and directly underneath the metal center.
Modelling shows that the longer side chain of the arginine
would project towards the penta-coordinated zinc site.
This would result in a profound change of electrostatics
due to the positive charge of the guanidinium group.
Indeed, the view of the active site presented by Carfi et al.
[26] shows this arginine residue in close proximity to the
aspartate and histidine residues, which are the ligands of
the penta-coordinated zinc in the B. fragilis structure.
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Figure 4
Amino acid sequence alignment of five
metallo-b-lactamases. The B. fragilis (BACFR)
and B. cereus (BACCE) b-lactamase
sequences were aligned first. The remaining
sequences from Serratia marscescens
(SEMAR), Aeromonas hydrophilia (AERHY),
and Xanthomonas maltophilia (XAMAL) were
aligned against the first two using secondary
structure-dependent gap penalties [73,74]. A
few more changes to the automatic multiple
alignment improved the conservation of the
binuclear zinc fingerprint. Shaded boxes
indicate zinc coordinating residues, and
unshaded boxed residues are proposed to be
critical for substrate binding. Secondary
structure elements were assigned using
DSSP and are shown above the sequence
[75]. The numbering corresponds to the
sequence of the B. fragilis enzyme. The matrix
at the bottom of the figure summarizes the
level of amino acid sequence identity.
The metallo-b-lactamase from A. hydrophila also contains
an arginine residue at position 104. This enzyme exhibits
the lowest catalytic efficiency [19,20]. It remains to be
determined whether the affinity for a second zinc binding
correlates with the catalytic efficiencies of the various
metallo-b-lactamases.
There are two more invariant amino acid residues in the
active site that may stabilize the Michaelis complex and/or
the the tetrahedral intermediate, Asn193 and Lys184.
This is with the exception of the more remotely related
enzyme from X. maltophilia where the lysine is replaced
by a serine residue. The proposed mode of substrate
binding highlights the role of these residues.
Steric strain and buried charges
Two non-glycine residues adopt sterically strained main-
chain conformations: Asp69 of both molecules in the
asymmetric unit, with (φ,ψ) dihedral angle values averag-
ing (81°,144°), and Asp142 of molecule B in a confor-
mation with (φ,ψ) values of (78°,-78°). The assigned
conformations are reliable, as these residues are associated
with well defined electron density and low crystallo-
graphic temperature factors. Asp69 is located at the
interface between the N- and C-terminal domains of the
molecule, in the vicinity of the active site, and with the
carboxylate moiety buried. The main-chain conformation
adopted by Asp69 is close to the left-handed helical region
and helps define a 90° turn in the direction of the
polypeptide chain. The turn is such that the side chain of
Asp69 interacts with groups that in turn assure the disposi-
tion and orientation of three zinc ligands: His99, Cys181
and Asp103 (Fig. 5). Hence, the strained conformation of
Asp69 may be relevant to the function of the enzyme.
Indeed, sterically strained amino acid residues in other
proteins are, on the whole, rather rare but tend to be asso-
ciated with active sites [46].
The sterically strained main-chain conformation of Asp142
is observed only in molecule B. It is part of a polypeptide
segment that is involved in crystal packing across the 
non-crystallographic twofold axis. In this context, if the
non-strained conformation observed in molecule A also
occurred in molecule B, it would lead to an unfavorable
electrostatic interaction between the main-chain carbonyl
groups of the two Asp142 residues.
There are two buried aspartate residues in the molecule
and both are associated with the active site. The first,
Asp69, has been discussed above, highlighting its role in
positioning zinc ligands. The refined model indicates that
Asp69 forms an ion pair (Fig. 5), probably with a sodium ion
that was present in the crystallization solution (the HEPES
buffer was titrated with NaOH). The ligands are all oxygen
atoms with an average distance of 2.4 Å. The coordination
geometry is trigonal bipyramidal; the sodium ion is coordi-
nated to the carboxylate group of Asp69, to two main-chain
carbonyl oxygen atoms (the apical positions), and to two
water molecules. The distance between the sodium ion and
the penta-coordinated zinc is 6.0 Å. It remains to be deter-
mined whether under physiological conditions this may be
a magnesium or a calcium-binding site.
The second buried aspartate residue, Asp165, is also
associated with positioning zinc ligands. One of the inter-
actions of its buried carboxylate group is with the 
main-chain nitrogen atom of Trp100. This interaction
facilitates the close proximity and the appropriate orienta-
tion of three zinc ligands: His99, His101 and His162.
Asp69 is invariant in all but the metallo-β-lactamase from
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Figure 5
Stereoscopic representation of the
environment of Asp69, a buried aspartate
residue with a sterically strained main-chain
conformation. The coloring scheme is as
described in the legend to Figure 3a. The
sodium cation is represented as a dark purple
sphere. With the exception of two water
molecules, Wat1 and Wat2, all solvent
molecules are internal. Zinc–ligand interactions
are shown as orange dotted lines. Other key
electrostatic interactions are shown as gray
dotted lines.
A. hydrophilia, and Asp165 is invariant in all but the
enzyme from X. maltophilia. Where they are conserved,
the two buried aspartate residues are likely to play a
similar role.
Proposed mode of binding of substrates
Requirements for shape, electrostatic, and functional com-
plementarity between the enzyme and the substrate
guided the modelling of bound β-lactams in the active-site
groove of the metallo-β-lactamase from B. fragilis (Fig. 6).
Three examples of different substrates have been accom-
modated in the active site, without invoking major confor-
mational adjustments of the protein. The three substrates
represent different types of antibiotic that are all suscepti-
ble to the B. fragilis enzyme: ampicillin, a penicillin with a
b side-chain substituent on the b-lactam ring; ceftazidime,
a third generation cephalosporin, with a bulky b side-
chain substituent; and imipenem, a penicillin with an
a side-chain substituent (the enantiomorphic stereochem-
istry of the more commonly used b substitution). Three
key assumptions help define the position and orientation
of the substrate. Firstly, the nucleophilic group, which is
most likely the shared hydroxide (Wat1), must be in close
proximity to the b-lactam’s carbonyl carbon atom. Sec-
ondly, the carboxyl moiety, common to all b-lactam sub-
strates, forms an electrostatic interaction with the amino
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Figure 6
Models of b-lactam substrates bound in the active site of the metallo-
b-lactamase from B. fragilis. The substrates, shown in magenta, are:
(a) ampicillin, (b) ceftazidime and (c) imipenem. The corresponding
chemical structures are displayed on the right. The coloring scheme is
as described in the legend of Figure 3a. In addition, the dark blue
dotted line shows the shared hydroxide’s proposed line of attack on
the carbonyl carbon of the substrate.
group of the invariant Lys184. Thirdly, the carbonyl
oxygen atom of the b-lactam bond forms an electrostatic
interaction with the side chain of the invariant Asn193 and
a more distant interaction with the tetrahedrally coordi-
nated zinc, Zn1. Together, Asn193 and Zn1 provide an
oxyanion hole that enhances the polarization of the b-
lactam’s CO bond upon binding. The oxyanion hole also
stabilizes the negative charge that develops on the tetra-
hedral intermediate during the reaction. Indeed, in the
crystal structure, a water molecule occupies the oxyanion
site, indicating that a partial negative charge is favored
there. The consequence of this binding mode is that the
nitrogen atom of the b-lactam bond is positioned in close
proximity to the apical water, Wat2. If the b-lactam model
is shifted by approximately 1.5 Å the apical water could
serve as the nucleophile. This pertains to the catalytic
mechanism as discussed below. With the shifted models,
the carboxyl moiety of the b-lactam compound forms a
tighter interaction with Lys184, however, the b-lactam’s
carbonyl group is displaced from the oxyanion hole.
A hydrophobic pocket, formed by the side chains of Ala44,
Ile46, Val52 and Ile72, complements the aromatic tip of
the b side-chain substituents of ampicillin and ceftazidime.
In the models shown in Figures 6a,b, the side chain has
been adjusted to occupy the hydrophobic pocket and to
orient the peptide’s carbonyl group towards the main-chain
amide groups of Gly102 and Asp103. Other combinations
of side-chain dihedral angles can be selected, in which the
peptide is oriented away from the above two amides but
the aromatic group still occupies the hydrophobic pocket.
Residues 45–51 that delineate part of the hydrophobic
pocket are associated with high crystallographic tempera-
ture factors (with residues 48–49 being completely disor-
dered) and comprise the end of a hairpin loop that
protrudes into the solvent (Figs 1,2,3). Conceivably, this
‘flap’ may adjust upon substrate binding to accommodate a
variety of b-lactam side-chain substituents.
For imipenem (Fig. 6c), the short a side-chain group can
not occupy the hydrophobic pocket. However, there is
enough space to accommodate this substrate even though
an a substitution results in a side chain that is oriented
towards the floor of the active site groove. Enhancement
of the binding energy may be provided by interactions
between the protein and the long side-chain substituent
attached to the five-membered thiazolidine ring, and pro-
jecting along the narrow groove. In the model, the con-
formation of this thiazolidine ring substituent has been
adjusted to form an electrostatic interaction with Asp185,
but as this is not an invariant residue, other interactions
may be involved.
The active-site groove is open at both ends (Fig. 2), 
and can accommodate the large side-chain substituents of
the fused six-membered ring typical of cephalosporins.
These substituents form good leaving groups during
cephalosporin hydrolysis. The kinetic data for the B. cereus
enzyme indicated that the rate limiting step in hydrolysis
is the formation of the tetrahedral intermediate, rather
than the release of the leaving group [47]. Structurally,
having an open groove enables the leaving groups to
diffuse away from the active site.
With the models of bound substrates in mind, the wide
spectrum substrate profile of the metallo-b-lactamase
from B. fragilis is attributed to a combination of structural
features. Firstly, when the shape and size of the active site
is compared with that of a class A b-lactamase [48] it 
is obvious that the active site of the metallo-b-lactamase 
is wider and less restrictive. This less restrictive site 
thus allows more latitude in accommodating substrates 
of varying size and shape. For example, a model of
imipenem cannot be accommodated in the active site of
the class A b-lactamase because its side chain substituent
is sterically hindered. Secondly, the inherent flexibility of
the b hairpin loop, in the B. fragilis enzyme (residues
44–51), may help compliment a wide variety of b-lactam
side-chain substituents.
The mode of binding presented here bears little resem-
blance to that sketched by Carfi et al. [26]. Their model of
bound cephalosporin implies that while the carbonyl
oxygen atom of the b-lactam ring interacts with the tetrahe-
dral zinc, and the carboxylate moiety forms a salt bridge
with His210 (His223 in the numbering scheme of the
B. fragilis enzyme), a nucleophilic attack on the b-lactam
ring is possible by the water molecule that interacts with
Asp90 (Asp103 in the current numbering scheme). This is
the water molecule located at the approximate position of
the penta-coordinated zinc in the B. fragilis enzyme. In our
hands, the orientation and the position of the substrate
cannot be reconciled in this manner, with either a water
replacing the penta-coordinated zinc or with the shared
hydroxide (Wat1) being assigned with the nucleophilic role.
The catalytic mechanism
The most attractive candidate to carry out the nucle-
ophilic attack on the carbonyl carbon of the b-lactam ring
is the shared hydroxide. Its interaction with Asp103 helps
orient the lone pair electrons for a re-face attack on the b-
lactam, and also modulates the strength of the hydroxide-
zinc interaction, so that the hydroxide is not too tightly
bound. This arrangement is reminiscent of other hydro-
lases with a binuclear metal center, for example urease,
with a binuclear nickel center [49] and phosphotriesterase,
with a binuclear cadmium center [40]. In these proteins a
solvent molecule which bridges the two metals ions, and is
postulated to exist predominantly in the form of a hydrox-
ide, is the proposed nucleophile. In b-lactamase an aspar-
tate residue coordinates via one carboxylate oxygen atom
to one of the metal ions, and simultaneously forms an
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electrostatic interaction with the hydroxide via the second
carboxylate oxygen atom.
By analogy with either single or binuclear metallo-hydro-
lases, the nucleophilic attack results in a negatively-
charged tetrahedral intermediate. Stabilization of this state
is provided by the oxyanion hole. The next step in the
reaction requires a proton to be transferred to the amide
nitrogen of the b-lactam bond. With the binuclear zinc
center of b-lactamase, the apical water, Wat2, is optimally
positioned to donate a proton (Fig. 6). Whether or not the
proton transfer is the rate limiting step is yet to be deter-
mined. Once Wat2 is converted into a hydroxide, it can
readily move to occupy the vacated Wat1 site, as the tetra-
hedral intermediate state decomposes and the degraded b-
lactam diffuses away from the active site. Finally, a water
molecule from the bulk solvent will re-occupy the apical
coordination site of the penta-coordinated zinc. 
A catalytic mechanism which invokes the apical water
molecule as the nucleophilic group and the shared hydrox-
ide as playing more of a structural role, by maintaining the
integrity of the zinc cluster, should not be ignored. Models
of bound substrates consistent with such a mechanism can
be derived. In favor of this model, it may be argued that
the apical water would be less tightly bound compared
with the shared hydroxide, and therefore might constitute
a better nucleophilic group. The inherent weaknesses of
the proposal are that there are no protein groups that are
appropriately positioned to assist with the proton transfer,
and the tetrahedral intermediate cannot be stabilized by
the oxyanion hole. Thus, although this alternative cat-
alytic mechanism cannot currently be ruled out, it is less
favored.
The pH dependence of the observed kcat values remains
relatively constant between the range pH 5–8 (Table 2).
This is consistent with the interpretation that the inter-
action with the two zinc ions dramatically reduces the pKa
of the shared hydroxide. This trend of pH dependence 
is quite different from the distorted bell-shaped curve
observed with the single zinc-bound form of the enzyme
from B. cereus [50]. For the B. cereus enzyme, the drop in
the catalytic rate at low pH implicated a group with a pKa
value of 5.1 for the substrate-bound state. On the other
hand, the observed Km of the B. fragilis b-lactamase
increases ten-fold as the pH is reduced from 8 to 5,
whereas the increase is only twofold for the B. cereus
enzyme. The B. fragilis b-lactamase data can be reconciled
by a kinetic model in which an ionizable group, presum-
ably the shared hydroxide, has a pKa value of 6.2 in the
free form of the enzyme. The pKa value is further
reduced to 4.2 upon substrate binding. Indeed, it makes
sense that upon desolvation of the active site by the sub-
strate the protonation of the hydroxide is less favorable
because the negative charge is required to compliment the
charges of the two buried zinc ions.
Could the B. fragilis metallo-b-lactamase function with a
single metal ion? By analogy with the crystal structure of
the B. cereus enzyme, if only one zinc ion was present it
would occupy the tetrahedral zinc site. The substrates
would bind in a mode not much different than that
proposed for the binuclear zinc center form. The nucleo-
philic water molecule would be located approximately
half way between the positions of the hydroxide and the
penta-coordinated zinc, forming electrostatic interactions
with Asp103 and His223. These two residues would
provide the assisting machinery for proton transfer. An
evolutionary progress towards an enzyme with a binuclear
center may be invoked because, with Asp103 and His223
in position to fulfill their role, most of the elements for
binding a second zinc ion are already in place. The third
ligand may be a cysteine or an aspartate residue, or even
just a water molecule. The elimination of any positively
charged side chain proximal to the metal site is also
required. The binuclear cluster may provide bacteria with
an evolutionary advantage, by assuring that the hydrolytic
water is always in an anionic form and that there is a
readily available second water to provide the proton. This
hypothesis may be simply tested by replacing Arg104
(B. fragilis numbering scheme) of the metallo-b-lactamase
from B. cereus by a cysteine residue and evaluating the
kinetic properties of the engineered enzyme. Alterna-
tively, the B. fragilis enzyme could be converted into an
enzyme with a second low affinity zinc-binding site.
Biological implications
The production of b-lactamases by pathogenic bacteria
has greatly diminished the usefulness of b-lactam antibi-
otics. The increasing number of metallo-b-lactamases
that have been identified in recent years raises further
concern about the effectiveness of one of the most pow-
erful families of therapeutic agents. The resistance of
B. fragilis to b-lactams, conferred by the metallo-b-lacta-
mase, is particularly alarming because this pathogen is
associated with post-surgery infections. Moreover, the
enzyme exhibits a broad-spectrum substrate profile and
is not clinically susceptible to any known b-lactamase
inhibitor. The report of plasmid-mediated dissemination
of the enzyme indicates future acceleration of acquired
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Table 2
Kinetic parameters for the hydrolysis of benzylpenicillin by
B. fragilis zinc b-lactamase.
pH kcat (s–1) Km (µM) kcat/Km (µM–1s–1)
5.0 332 180.0 1.8
6.0 290 63.8 4.5
7.0 247 23.7 10.4
8.0 277 18.3 15.1
resistance to b-lactams by related bacteria. The crystal
structure determination of the enzyme was undertaken
to gain insight into the catalytic mechanism and to assist
with the drug design effort.
Despite the similarity in fold and disposition of active-
site residues, the metallo-b-lactamase from B. fragilis
was found to contain a binuclear zinc center, whereas
the enzyme from B. cereus contains only a single zinc
ion. This surprising finding is intriguing in terms of the
evolution of the active sites. The current work provides
the structural basis for understanding the differences
that may have led to the lower zinc-binding affinity to
the potential penta-coordinated site in the B. cereus
enzyme. This study also reveals that the fingerprint for
the binuclear zinc center is conserved in all the metallo-
b-lactamases of known sequence. Whether the catalytic
efficiency of each of the metallo-b-lactamases corre-
lates with the affinity to the second zinc ion is not 
yet known.
A new model for bound substrate is proposed, implying
that a hydroxide group, that coordinates to both zinc
ions, serves as the nucleophilic group; the proton is pro-
vided by a water molecule that coordinates to the penta-
coordinated zinc. In addition to the invariant residues
that are required for metal binding, two more invariant
residues are implicated in function. The first of these is
an asparagine residue the side chain of which, together
with the tetrahedral zinc ion, forms an oxyanion hole.
The second residue is a lysine whose amino group com-
pliments the charge of the carboxylate moiety, typical of
all b-lactam antibiotics. The broad-spectrum substrate
profile of metallo-β-lactamase arises from the rather
wide groove where b-lactam compounds of various size
and shape can be accommodated. In addition, the flexi-
bility of a b hairpin loop associated with the active site
indicates that it may adopt its conformation to comple-
ment a variety of b-lactam side-chain substituents.
Materials and methods
Crystallization and data collection
The CcrA3 gene of the metallo-b-lactamase from B. fragilis (isolated 
at Queen’s Medical College, London [QMCN3]) was cloned and
over-expressed in E. coli. The protein was purified as described previ-
ously [16,21]. The polypeptide chain consists of amino acids 18–249
with a molecular mass of approximately 26 kDa [16]. The signal
sequence comprising residues 1–17 has been omitted from the cloned
gene. Single crystals of the Zn2+-bound b-lactamase have been
obtained at room temperature by vapor diffusion in hanging drops. The
protein drops were prepared by mixing 5 µl of 5–8 mg ml–1 protein
solution (in 10 mM HEPES, pH 7.0, and 10 µM ZnCl2) with 5 µl of
reservoir solution containing 26–28% PEG 2000, buffered at pH 7.0
by 0.1 M HEPES. The drops were equilibrated against 500 µl of
reservoir solution for 1–2 weeks, after which the crystals reached a
maximum size of 0.25 x 0.25 x 0.6 mm3. The crystals belong to the
tetragonal space group P43212 with unit cell dimensions a=b=78.3 Å,
c=140.9 Å. There are two molecules in the asymmetric unit, and the
solvent constitutes 40% of the cell.
The crystals are very sensitive to X-rays and to avoid radiation damage
cryocrystallographic techniques have been employed for all data col-
lection, using glycerol as the cryoprotectant. The crystals were trans-
ferred into 10 µl dialysis buttons, and dialyzed for 4–48 h against a
solution containing 30% PEG 2000, 0.1 M HEPES at pH 7.0, and
18% glycerol. The crystals were transferred into a nylon fiber loop
(Ethilon 10-0 ophthalmic 0.2 m) glued to a glass capillary tube [51].
Flash-freezing of the crystals to approximately 120K was achieved with
a modified Enraf-Nonius FR558 liquid nitrogen cryostat. X-ray diffrac-
tion data from the native crystals and crystals soaked with heavy-atom
derivative solutions were collected in-house using a Siemens multi-wire
area detector mounted on a three-circle goniostat. Monochromated
CuKa X-rays were supplied by a Rigaku R200BH rotating-anode gen-
erator operating at 100 mA x 40 kV. Oscillation steps of 0.20° or 0.25°
were sampled about the goniostat’s ω-axis, using crystals whose
mosaic spread were typically 0.7–0.8°. The freezing did not alter the
unit cell dimensions significantly.
The data were processed using the XENGEN computer package 
[52]. Native data were collected at 1.85 Å resolution (Table 3). Of 
the numerous heavy-atom derivative replacement experiments only 
two produced interpretable diffraction changes: CdCl2, which was
obtained from a protein sample that was renatured in the presence of
the cation; and K2HgI4/KI, which was soaked into the crystal. The data
were useful only at low resolution and the resulting electron-density
map was uninterpretable.
Multiwavelength anomalous diffraction (MAD) data [53,54] were col-
lected from a native, Zn2+-bound protein crystal, exploiting the K
absorption edge of the intrinsic zinc (1.238 Å, 9.66 keV). The MAD
data were collected at the X12C beamline of the National Synchrotron
Light Source (Brookhaven National Laboratory, Upton, NY). All data
were obtained from a single crystal that was flash-frozen using the
Oxford Cryosystem. The crystal revealed an unexpectedly strong fluo-
rescence X-ray absorption near-edge structure signal, which in retro-
spect is attributed to the close association of two zinc ions (Fig. 7).
Diffraction intensities to 2.0 Å resolution were recorded on a 300 mm
MAR research image plate, sampling oscillation steps of 1.0°, and
using the inverse-beam strategy (rotation of the crystal by 180° to
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Figure 7
Fluorescence X-ray absorption spectrum of the single crystal of zinc
b-lactamase from B. fragilis used for data collection. X-ray diffraction
data were collected at nominal incident X-ray energies of 9.6575 (l1),
9.6637 (l2) and 9.9188 (l3) keV. F is measured in arbitrary units.
obtain the Bijvoet pairs). Data acquisition was controlled with the
computer program MADNES [55], driven by a graphical user interface
(R M Sweet, J Skinner, [abstract 1a.7.A.], American Crystallographic
Association Annual Meeting, Montreal, Canada, 1995). Measurements
were taken at three wavelengths corresponding to the zinc’s K
absorption edge inflection point (λ1=1.2830 Å), peak (λ2=1.2838 Å),
and a remote high-energy point (λ3=1.2500 Å). The intensity data
were processed with the DENZO/SCALEPACK computer programs
[56]. The statistics of data collection are shown in Table 4.
Structure determination
The multiwavelength data were treated as arising from MIR experi-
ments following protocols described previously [57,58]. The data
measured at wavelength λ1 were chosen as the ‘native’ set, while the
data sets at λ2 and λ3 were treated as ‘derivatives with anomalous
scattering’. The anomalous differences ∆F+/-(λ2) were used in
SHELXS-90 to calculate the difference anomalous Patterson function,
which was interpreted by the Patterson superposition minimum func-
tion method [59]. The analysis showed unambiguously that there are
four zinc sites in the asymmetric unit, corresponding to each b-lacta-
mase molecule binding two Zn2+, 3.5 Å apart. The CCP4 suit of pro-
grams [60] was used to prepare the data for phasing. The positions,
isotropic temperature factors, and the dispersive and anomalous
occupancies of the four zinc scatterers in the asymmetric unit were
refined at 2.4 Å resolution using the program MLPHARE [61] as
implemented in CCP4. The four sites refined with approximately the
same occupancy values (Table 5). Cross-difference Fourier maps of
the mercury and the cadmium derivatives, calculated with phases gen-
erated by the MAD experiment, confirmed that the space group is
P43212 and not P41212. The MAD-phased electron-density map at
2.4 Å resolution was readily interpretable. The phases were further
improved by solvent flattening techniques [62] as implemented in the
computer program DM [63], and by applying non-crystallographic
averaging using the computer program RAVE [64,65]. All three maps
(i.e. the MAD-phased map, the solvent-flattened map, and the aver-
aged map) were used to trace the polypeptide chain using the interac-
tive computer graphics program O [66] running on a Silicon Graphics
INDIGO 2 workstation.
Structure refinement
The computer program package X-PLOR [67] was used to refine the
structure (Table 6). The initial model included most of the amino acid
residues and the zinc ions. The model was refined against the 1.85 Å
diffraction data collected on the Siemens area detector. The progress
of the refinement was evaluated from the improved quality of the elec-
tron-density maps and the values of the conventional R and Rfree [68].
The improvement of the electron-density maps enabled the tracing of
all but a few residues. The first cycle of refinement included a slow-
cooling step in the range 3000 K to 300 K, followed by positional
refinement and by individual temperature factor refinement. Electron-
density maps with the coefficients 2|Fo|-|Fc| and |Fo|-|Fc| and calculated
phases were used to adjust the model on the interactive graphics
system. At the early stages of refinement non-crystallographic symme-
try restraints were applied, but later, the two molecules in the asymmet-
ric units were refined independently. Charged residues and sodium
and zinc ions were refined as neutral, and no restraints were applied
between the zinc ions and their ligands. Solvent molecules were
assigned by a peak search of the difference Fourier map. The cut-off
level for inclusion in the model was 3.5σ of the rms density. During the
last four rounds of positional refinement, the 10% of the reflections
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Table 4
Data processing statistics for the MAD data set.
Data l Maximum Rsym* Completeness Redundancy*
set (Å) resolution (%)
(Å)
l1 1.28386 2.0 0.039 (0.043) 79.8 6.6 (12.3)
l2 1.28306 2.0 0.041 (0.060) 92.6 5.6 (10.3)
l3 1.25000 2.0 0.039 (0.047) 79.7 6.6 (12.2)
*Rsym= Σi,(hkl)|Ii,(hkl)–〈I(hkl)〉|/Σi,(hkl)〈I(hkl)〉, where 〈I(hkl)〉 is the average
intensity of symmetry equivalent reflections. Rsym values correspond to
unmerged Bijvoets pairs. Rsym values for merged Bijvoets pairs are
listed in parentheses. Similarly, the redundancy values correspond to
unmerged and merged Bijvoets pairs.
Table 3
Data processing statistics for the native data set.
Shell No. of reflections No. of 〈I/σ(I)〉 Rsym*
lower Possible Collected observations
limit  
(Å) 
3.36 6693 6671 69 777 49.3 0.050
2.67 6409 6409 67 124 22.4 0.081
2.33 6324 6324 48 345 9.7 0.143
2.12 6274 6274 42 663 6.4 0.196
1.97 6252 6232 37 170 3.9 0.274
1.85 6257 5995 27 319 1.7 0.398
Total 38 209 37 905 292 398 16.1 0.077
*Rsym= Σi,(hkl)|Ii,(hkl)–〈I(hkl)〉|/Σi,(hkl)〈I(hkl)〉, where 〈I(hkl)〉 is the average intensity of symmetry equivalent reflections.
previously used for the calculation of the Rfree values were included in
the refinement, and the energy minimization was applied without elec-
trostatic terms.
Enzyme kinetics
Kinetic measurements were made on a Gilford 250 spectropho-
tometer, using freshly prepared benzylpenicillin (extinction coefficient
∆ε240=540 M-1cm-1). All assays were performed at 25°C in 50 mM
phosphate buffer. The concentration of Zn2+ in the protein solution was
10 µM. Initial steady-state rates were obtained at 6–7 substrate con-
centrations. Experiments spanned the pH range 5–8. The data were
analyzed with the computer program ENZPACK (Elsevier).
Accession number
The atomic coordinates have been deposited in the Brookhaven
Protein Data Bank with the accession code 1ZNB.
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